Related Experiment Video
Updated: Jul 9, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Inhibition of osteosarcoma cell proliferation by the Hedgehog-inhibitor cyclopamine
J Warzecha1, S Göttig, K U Chow
1Department of Orthopedic Surgery, Johann Wolfgang Goethe-University Hospital, Frankfurt am Main, Germany. j.warzecha@friedrichsheim.de
Abstract:
Osteosarcomas (OS) are the most frequent primary malignant bone tumors in humans. Even though OS are chemosensitive, about 30% of patients must be considered poor responders and consequently have a dismal long term prognosis. The Hedgehog (Hh) gene is crucial in the signalling pathways of proliferation and differentiation during embryonic development. There is evidence that uncontrolled activation of this pathway results in specific types of cancer and that inhibition of Hh signalling is able to suppress tumour growth and to induce apoptosis of neoplastic cells. This study investigates the impact of the steroidal alkaloid and Hh-inhibitor cyclopamine on osteosarcoma cells. Thus we demonstrate the drug's impact on cellular proliferation, cell cycle cell death as well as the cells' metabolism. We here demonstrate that cyclopamine exhibits a high efficacy against the osteosarcoma cell lines HOS, SaOS and OS-KA, a self-established primary osteosarcoma cell line. In particular, cyclopamine is able to inhibit proliferation and to promote cell death. Our results provide evidence for the potency of the Hh-inhibitor cyclopamine as a future treatment of osteosarcomas.
Insights
Cyclopamine, a Hedgehog (Hh) signaling inhibitor, effectively combats osteosarcoma cells by reducing proliferation and inducing cell death. This study highlights cyclopamine
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcomas (OS) are primary malignant bone tumors with poor prognosis for non-responders to chemotherapy.
- The Hedgehog (Hh) signaling pathway is implicated in embryonic development and cancer progression.
- Inhibiting Hh signaling has shown potential in suppressing tumor growth and inducing apoptosis.
Purpose of the Study:
- To investigate the efficacy of cyclopamine, a steroidal alkaloid and Hh inhibitor, against osteosarcoma cells.
- To assess the impact of cyclopamine on osteosarcoma cell proliferation, cell cycle, cell death, and metabolism.
Main Methods:
- Treatment of established osteosarcoma cell lines (HOS, SaOS) and a primary cell line (OS-KA) with cyclopamine.
- Analysis of cellular proliferation, cell cycle progression, apoptosis induction, and metabolic changes.
- Evaluation of the Hedgehog signaling pathway inhibition by cyclopamine.
Main Results:
- Cyclopamine demonstrated significant efficacy across all tested osteosarcoma cell lines.
- The drug markedly inhibited osteosarcoma cell proliferation and promoted significant cell death (apoptosis).
- Cyclopamine treatment altered cellular metabolism in osteosarcoma cells.
Conclusions:
- Cyclopamine exhibits potent anti-cancer activity against osteosarcoma cells.
- Hedgehog pathway inhibition via cyclopamine represents a promising therapeutic strategy for osteosarcoma treatment.
- Further investigation into cyclopamine as a potential therapeutic agent for osteosarcoma is warranted.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Positive Regulator Molecules

